Pharmacogenetics - challenges and opportunities ahead.
作者信息
Zanger Ulrich M
机构信息
Robert-Bosch Foundation, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart, Germany.
出版信息
Front Pharmacol. 2010 Aug 20;1:112. doi: 10.3389/fphar.2010.00112. eCollection 2010.
Abstract
摘要
相似文献
1
Pharmacogenetics - challenges and opportunities ahead.
Front Pharmacol. 2010 Aug 20;1:112. doi: 10.3389/fphar.2010.00112. eCollection 2010.
2
Pharmacogenetics in Cardiovascular Medicine.
Curr Genet Med Rep. 2016 Sep;4(3):119-129. doi: 10.1007/s40142-016-0096-z. Epub 2016 Jun 16.
3
The promise and reality of pharmacogenetics in psychiatry.
Clin Lab Med. 2010 Dec;30(4):931-74. doi: 10.1016/j.cll.2010.07.004.
4
Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.
Pharmacogenomics. 2010 Feb;11(2):237-47. doi: 10.2217/pgs.09.176.
5
Pharmacogenetics in multiple sclerosis: the long and winding road ahead of us.
Arq Neuropsiquiatr. 2018 Oct;76(10):647-648. doi: 10.1590/0004-282X20180115.
6
Resequencing the sulfotransferase SULT1 gene provides new insights, while illuminating challenges that lie ahead for pharmacogenomics.
Pharmacogenetics. 2001 Dec;11(9):745-6. doi: 10.1097/00008571-200112000-00001.
7
The promise and reality of pharmacogenetics in psychiatry.
Psychiatr Clin North Am. 2010 Mar;33(1):181-224. doi: 10.1016/j.psc.2009.12.001.
8
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:65-84. doi: 10.1146/annurev-pharmtox-030920-025745. Epub 2020 Oct 2.
9
[Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].
Praxis (Bern 1994). 2004 Mar 3;93(10):359-65. doi: 10.1024/0369-8394.93.10.359.
10
Challenges and opportunities of pharmacogenetics in drug development.
Per Med. 2006 May;3(2):195-206. doi: 10.2217/17410541.3.2.195.
引用本文的文献
1
From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine.
Health Inf Sci Syst. 2023 Dec 18;12(1):6. doi: 10.1007/s13755-023-00264-5. eCollection 2024 Dec.
2
Pharmacogenomics of Hypertension Treatment.
Int J Mol Sci. 2020 Jul 1;21(13):4709. doi: 10.3390/ijms21134709.
3
Pharmacogenomics And Hypertension: Current Insights.
Pharmgenomics Pers Med. 2019 Nov 22;12:341-359. doi: 10.2147/PGPM.S230201. eCollection 2019.
4
Pharmacy students' attitudes and perceptions toward pharmacogenomics education.
Am J Health Syst Pharm. 2019 May 17;76(11):836-845. doi: 10.1093/ajhp/zxz060.
5
Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
J Pers Med. 2018 Jul 24;8(3):24. doi: 10.3390/jpm8030024.
6
Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions.
Front Pharmacol. 2018 Feb 28;9:168. doi: 10.3389/fphar.2018.00168. eCollection 2018.
7
Pharmacogenomics, Theranostics and Personalized Medicine - the complexities of clinical trials: challenges in the developing world.
Appl Transl Genom. 2013 May 14;2:17-21. doi: 10.1016/j.atg.2013.05.002. eCollection 2013 Dec 1.
8
DMET-analyzer: automatic analysis of Affymetrix DMET data.
BMC Bioinformatics. 2012 Oct 5;13:258. doi: 10.1186/1471-2105-13-258.
Zotero 插件